HomeNXTCL • STO
add
NextCell Pharma AB
Previous close
kr 1.94
Day range
kr 1.85 - kr 2.02
Year range
kr 1.16 - kr 4.03
Market cap
143.99M SEK
Avg Volume
297.35K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | May 2024info | Y/Y change |
---|---|---|
Revenue | 2.48M | -40.75% |
Operating expense | 8.79M | -30.55% |
Net income | -8.82M | 19.19% |
Net profit margin | -355.36 | -36.40% |
Earnings per share | — | — |
EBITDA | -8.90M | 20.26% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | May 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 20.80M | -67.11% |
Total assets | 61.12M | -36.08% |
Total liabilities | 14.11M | 24.45% |
Total equity | 47.02M | — |
Shares outstanding | 34.38M | — |
Price to book | 1.42 | — |
Return on assets | -34.19% | — |
Return on capital | -43.77% | — |
Cash Flow
Net change in cash
(SEK) | May 2024info | Y/Y change |
---|---|---|
Net income | -8.82M | 19.19% |
Cash from operations | -9.69M | 21.79% |
Cash from investing | — | — |
Cash from financing | 93.07K | -57.65% |
Net change in cash | -9.60M | 33.31% |
Free cash flow | -6.49M | 39.52% |
About
Founded
2014
Website
Employees
17